What is Annexon's change in AP?

Annexon (ANNX) reported change in AP of $2.15M in Q1 2026.

How has Annexon's change in AP changed year-over-year?

Annexon's change in AP increased by 7038.7% year-over-year, from -$31K to $2.15M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Annexon ANNX Change in AP

Change in AP at other companies

Regeneron PharmaceuticalsREGN

$107.7M+150%

OmerosOMER

-$979K+80.6%

Vor BiopharmaVOR

-$9.1M-563%

Cullinan Therapeutics, Inc.CGEM

$1.67M-3.1%

Nektar TherapeuticsNKTR

-$934K-115%

AnaptysBio, Inc.ANAB

-$17.82M+25.9%

Other financials

Income statement

See full

Operating income-$46.1M+19.8%

Net income-$44.1M+18.8%

EPS (diluted)-$0.23+37.8%

Balance sheet

See full

Cash & equivalents$175.2M+80.4%

Total debt$25.4M-10.2%

Total equity$204.5M-16.1%

Total assets$262.9M-13.2%

Cash flow

See full

Operating cash flow-$46.8M+6.5%

CapEx--100%

Free cash flow-$46.8M+6.6%

Valuation

See full

Market cap$868.37M+223%

Enterprise value$718.59M+261%

Returns & leverage

See full

Return on equity-87.6%+42.3pp

Debt / equity0.1×0.0×

Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Annexon's change in AP?: Annexon (ANNX) reported change in AP of $2.15M in Q1 2026.
How has Annexon's change in AP changed year-over-year?: Annexon's change in AP increased by 7038.7% year-over-year, from -$31K to $2.15M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.